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Shifting Perimeters': Social and Ethical Implications of Human Genomics Research
Introduction
Representing emergent global assemblages of science-techno-capital power, research
on the human genome has made quick alliances with market networks, flexible capital,
and global research. Despite the growth of human genomic research (HGR) and its
presence in a wide array of possible uses, the ethical, legal, and social implications (ELSI)
of human genomics have largely been reduced to a footnote. Research on the human
genome and its allied science and technical engagements stand to be read at multiple
levels: as new information which has implications for a range of disciplines; as sources
for new medical knowledge that can be deployed against a range of diseases; as the
prototype for new organizational structures for conducting science and technology
research; as holding the mastercode to the possibilities of remaking the physiological
constitution of humans; as commercialized knowledge in which humans can exercise
their choice and options to redefine the physical and social body; and as a body of
knowledge that has the potential to alter the perimeters between science and society and
the very constitution of a range of disciplines.
'Shifting Perimeters':
Social and Ethical Implications
of Human Genomics Research
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In seeking articulations over these issues and concerns, this seminar was a preliminary
conversation to bring together understandings and interpretations related to several
questions:
1. What are the potentialities of the body of knowledge of human genomics? What
significance does it have for the disciplines of medicine, neurobiology, psychiatry,
sociology, anthropology, political science, public administration, jurisprudence, and
history?
2. What regimes (legal, ethical, political) are required to manage the linkage of human
genomics research and its use in a wide variety of fields?  What significance does
human genome research have for the increasingly market-based, commercial, and
profit-oriented research enterprises ?
3. What are the potential advantages and disadvantages that countries, such as India,
face in the conduct, dissemination and use of human genomic research?
4. What national and international regimes (legal and ethical) are required to ensure
that knowledge and information from human genomic research is used as a public
good and, therefore, what new transnational regulations are required to ensure this?
5. What are the implications of the use of human genomic research in the fields of a
range of new medical knowledge (psychiatry, psychology, physiology etc) and
practices (such as personalized medicine; profiling; predictive genetic testing etc)?
What ethical and legal concerns need to be borne in mind even as these gain wide
usage?
6. What are the larger universal concerns relating to the possibilities of using human
genomic research to alter the physiologies of humans and hence what larger ethical
and philosophical issues can be raised about the very constitution and understandings
of the ‘human’?
Bringing scholars from India, the United States of America, United Kingdom, South Africa,
and the Netherlands, the international seminar held at NIAS, jointly organized by the Indian
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Institute of Advanced Study, Shimla, and the National Institute of Advanced Studies,
Bangalore addressed some of the concerns and issues and concluded with a call for
further studies and policies related to the understanding and regulation of human genomics
research.  Part I of the report is a summary of the presentations and discussions. Part II
is a summary of the concluding discussions and recommendations to take the
discussions forward.
Part I
The Ethical, Social and Legal Implications (ELSI) of human genome research received a
major push in the Human Genome Project. Although concerns about the abuse of genetics
and apprehensions about possible misuse of science in the name of eugenics are not
new, the rapid developments in genomics, information and communication technologies,
and in emerging technologies such as nanotechnology have given rise to many new
questions and new issues and challenges for academics, policy makers and perhaps for
human kind itself. Issues like privacy, intellectual property rights over genetic materials,
sharing of genetic resources/materials and developing regulatory regimes can no longer
be considered as issues that are of relevance only to developed countries.
Given the rapid globalization of knowledge and its applications social scientists cannot
afford to be complacent in their assessments about Ethical, Social and Legal Implications
and this is all the more true of law and policy makers as laws and regulatory regimes
struggle to cope with technological developments and need frameworks that are adequate
enough to perform what has been called as ‘Real Time Technology Assessment’ and
think in terms of anticipatory governance.
In his opening remarks Prof. Peter de Souza (Director, Indian Institute of Advanced Study,
Shimla) made it clear that this was not yet another seminar but a prelude to a conversation
among scientists and social scientists. He underscored the implications of developments
in science and technology for the conceptual frameworks in social sciences. He spoke
about the beginnings and the broader mandate of IIAS and explained how this conference
fitted well with the mandate and agenda of IIAS. He stressed the importance of an enduring
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conversation among scientists and social scientists and expressed the view that such a
conversation should be sustained over a period of time. He spoke about the new issues
in ethics, policy research, and regulation in the wake of research on the human genome
and suggested that this terrain was not yet explored. According to him the conversations
among the inhabitants of the two epistemic worlds should result in co-operation and
better understanding of the risks, limitations and implications of the scientific knowledge
gained from projects like Human Genome Mapping. Elaborating this further he specified
four clusters that needed further research and exploration. The first cluster was that of
promises and possibilities of the new science and our capacity to process the data and
understand the promises, risks and possibilities arising out of this Mapping. The second
cluster was that of ethical issues that spanned various levels ranging from individual,
group to community and the range of issues included discrimination, privacy, genetic
profiling, questions of choice and consent and ethical issues in interventions at different
levels of human society and whether we should choose the techniques just because they
are available. In the third cluster he placed questions like what were the implications of
these developments in genetics, particularly from a social science perspective,
understanding of concepts such as person, privacy, choice, intergenerational justice,
regulation etc. Prof deSouza wondered whether our current concepts are sufficient enough
to cope up with the implications and impacts of the advances in scientific knowledge and
practice and he alerted us to the emergence of new concepts such as bio-colonialism
and bio-piracy. The fourth cluster of issues was that of regulation, policy making and the
capacity of institutional frameworks to deal with the advances in knowledge. He put forth
some pertinent questions in this regard and illustrated them with the story by Arthur Clark
(Rendezvous with Rama).
Welcoming the participants, on behalf of the National Institute of Advanced Studies,
Bangalore, Prof. B. V. Srikantan (Visiting Professor, NIAS) spoke about the beginnings of
NIAS and the vision of Mr. J.R.D.Tata, who envisaged NIAS as an institution for inter-
disciplinary research where scientists and social scientists were equally at home. He
talked about the programmess being offered at NIAS, the courses that were organized at
NIAS. He briefly explored the significance of knowledge explosion and illustrated that with
developments in an exciting and new field in physics- nuclear reactions at low temperatures
and was of the view that developments in this field would be of much importance in
biology.
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Prof. Wiebe E. Bijker (Professor of Science & Technology of Society Studies, Maastricht
University, The Netherlands), a doyen in STS, made a presentation titled ‘The Governance
of Risk and Benefits of Genome and Engineering- Related Experiences in Europe’. His
presentation addressed two important and contentious issues – scientific expertise and
democracy and how democracies can deal with uncertain science. Based on the
experiences in the Netherlands to study and understand the trends in biotechnology that
may need policy intervention he offered two examples – the $1000 genome (i.e. genome
sequencing of an individual at a cost $1000) and the application of biotechnology in health
care (e.g. stem cells, personalized medicine, and gene therapy)- to indicate how the
Biotechnology Trend Report by a committee consisting of scientists and social scientists
walked a fine line between expertise and judgment and thereby brought expertise to policy
making. He discussed in detail the new risks in handling Human Genome Research such
as indications of potential hazard although hard scientific proof was not available and
hence the adequacy of current regulations was not clear. He stressed on the need to
understand these new risks and underlined the importance of ‘risk governance’. Elaborating
this further by looking at nanotechnology as a case study he specified the different types
of risks (simple, complex, uncertain and ambiguous) and the associated issues that
focused. He observed that  risk situations needed different approaches and accordingly
the involved groups would be different in each case while the core question however
remained the same i.e. who decides. These debates on risks and expertise, and
involvement of different groups, were a challenge to democracy particularly to democratic
governance. He gave the example of the Dutch Societal Dialogue on Nano technologies
as an experiment in science and democracy that dealt with ‘serviceable truth’ without
compromising on scientific quality. According to him HGR would remake boundaries
between science and society, regulation and democracy, and experts and citizens. These
tensions, hence, called for engagements between science and democracy, for building
conversations across disciplines.
In the discussion on his presentation several interesting questions were raised; on, inter
alia, whether such experiments are unique to Netherlands, and if democratization of science
and innovation were possible by stakeholders such as patient groups. Prof. Bijker reiterated
that he was all for democratization in policy making and involvement of different
stakeholders in decision making on new risks and new opportunities from developments
in technology.
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In his paper, ‘Beyond ELSI’, Prof. Sasheej Hegde (Professor, Dept of Sociology, University
of Hyderabad) discussed the emergent forms of life and the ‘morality’ of HGR, and issues
that go beyond the typical ELSI approach to HGR. Drawing upon the works of Michael
Fischer and Nikolas Rose, Hegde  linked the ideas of both with that propounded by Michel
Foucault  on biopolitics. He underscored that there was more to molecularization  than
explanations as molecularization was reorganization of the gaze of life sciences and its
regimes, and practices, and, included both possibility and uncertainty. According to him
this would mean that HGR was both conservative and revolutionary and the HGR thus
posed a challenge to science studies. In other words we would have to be aware of both
the relentless pursuit of modern biosciences and the reifications particularly through fixed
conceptual forms and megaprojects. He had put forth a complex set of arguments and
brought in ideas used by scholars in diverse disciplines in their pursuit to understand
biopolitics and projects such as HGR.
Prof Sharat Chandra (Emeritus Professor, Indian Institute of Science) as chairperson of
the session on HGR and ethics, shared some of his recent observations and experiences
related to genetic research. He elaborated on how research on Downs’ Syndrome during
the last half century had advanced our understanding of the disease but the treatments
available had given rise to new challenges and issues that were not anticipated before.
Genetic testing of embryos  had brought in the possibility of predicting the chances of the
baby born with Downs Syndrome and this itself raised many ethical issues as it gave the
option of abortion if the parents chose not to beget a child with this syndrome. On the
other hand, thanks to diet regimes and other approaches to improve the autonomy of
children with Down’s Syndrome, their lifespan had increased. As a result, at least, some
of the children outlived their parents. This had implications for care and support for these
grown up persons with the Syndrome. As the family norms and obligations were undergoing
change new issues had arisen. He also pointed out the insensitivity of experts to human
suffering as they were more keen to pursue research on disease models based on mice
than on finding cures or therapies that would enable parents to increase the intellectual
capacities of those born with the Syndrome. He highlighted how a leading scientist who
had earlier worked on this was aghast with the developments that enabled abortion as an
option and how his own work could not attract funding in the later years. Prof. Chandra’s
talk underscored the need to pursue scientific research that is geared to finding solutions
besides advancing knowledge and pointed out the ethical issues and dilemmas faced by
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parents in using techniques like genetic testing of embryos for possible genetic ‘defects’
and ‘undesirable’ syndromes.
Prof. Madhava Menon (Radhakrishnan Chair of Rajya Sabha), began his talk with the
issue of the use of endosulfan and the controversy over its continued use in Kerala and
the suggestions to ban it. He traced the roots of modern concern and fear about the dark
sides of science with the development of the atomic bomb and its use in Hiroshima and
Nagasaki. He posited that pursuit of knowledge and all human activity should be for human
well-being and this objective would be the touchstone to check the legitimacy of any such
activity. Drawing upon the Universal Declaration of Human Rights (UDHR) and the
fundamental rights as enshrined in the Constitution of India he argued that these provided
the core principles in regulating research and in regulating science and technology.
According to him, in a democracy where the rule of law accepted irreducible human
values some activities could be prohibited if the outcome would negate or diminish those
values. But these are not fixed and as international norms and jurisprudence on human
rights continued to evolve, issues like informed consent, right to privacy, etc acquired
new meanings, and new approaches were necessary. But several unresolved issues
like patenting of human genes and ensuring fair and equitable benefit sharing in commercial
transactions remained. He highlighted the   ethical and regulatory issues in clinical trials
in India and wondered whether the current legal regime was adequate to protect public
health in trails. He pointed out that while this looked fine and reasonable in theory, in
practice the core issue was that of enforcement and authority to regulate as all stakeholders
might not come under the jurisdiction of the same legal authority. Calling for a balance
between regulation and research, he suggested that preventive strategies could play an
important role in safeguarding the interests of vulnerable sections.
In the discussions that followed, a question about the conflict between fundamental rights
and Directive Principles in the Constitution was posed and it was suggested that the legal
regime might end up legitimizing some activities in the name of regulation and hence the
logic and rationale behind the idea of regulation and the corresponding cost-benefit
approach should be questioned. Prof. Menon was of the view that potential conflicts could
be resolved and a balanced approach could be evolved. In response to this it was suggested
that an anticipatory legal framework would be needed and the risk/benefit approach could
be used instead of cost/benefit analyses.
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In his opening comments on the session on bioethics, Prof Vinod Gaur (Visiting Professor,
Indian Institute of Astrophysics, Bangalore) discussed the challenges posed by the
explosion of knowledge and the internationalization of this acceleration. According to him
this, in the context of genetic research, could result in genetic exclusion and hierarchy
and a system of exclusion. He called for a harmonization of knowledge and values  and
observed that in our search for knowledge we should not ignore principles such as the
sense of justice and respect for diversity.
Dr. Ratna Puri’s (Gangarams’ Hospital, New Delhi) presentation underscored the importance
of HGP for diagnostics and therapeutics. She discussed the issues in genetic counseling
and the factors that influence patients in genetic counseling. Eschewing an approach that
divides choices as absolute rights or absolute wrongs she focused on the interface between
law, ethics and culture in genetic counseling and laid emphasis on the basic ethical principles
to be followed by doctors and counselors. Dr. Puri highlighted the fact that the burden of
genetic diseases at birth in India was high and yet there were only 47 genetic counseling
and testing centres in India. In addition, the absence of affordable treatments and lack of
insurance coverage force parents to consider prevention as a priority and with increasing
acceptance of abortion as a choice prenatal diagnosis was in great demand. She gave
examples from her experience and discussed how patients wanted directive advice from
doctors as they were considered to be experts and preferred doctors to tell them what they
should do rather than take decisions based on counseling alone. Citing from her experience,
Dr. Puri argued that while there was an increase in the number of couples who preferred
testing and counseling, the decision making was not a question of simple choice as families
had a role to play. According to her, the previous incidences of genetic disorders in extended
families and increased awareness had resulted in more couples, particularly the educated
ones, opting for these tests sometimes even before marriage lest they should beget a child
with a genetic disorder or symptom. But the knowledge outcome of the tests was like a
double edged sword in predictive testing and the response could range from guilty feeling to
depression or helplessness. Her experience suggested that there was a preference to
know than not to know or do the predictive testing and for several reasons test results were
not shared with family members. She argued that prenatal testing could help in reducing
the burden of genetic diseases and prenatal testing was often sought for genetic defects
such as deafness and albinism. Drawing upon a controversial case on whether to permit or
not an abortion of a 26 week foetus, as the fetus had cardiac abnormalities, she suggested
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that many women acted as autonomous and responsible decision-makers despite family
and social constraints and considered genetic testing as their duty to the family and to the
unborn child. In the latter part of her presentation she dwelt upon the challenges of ethical
practices in genetics, in light of the increasing use of ART and direct to consumer genetic
testing. She discussed the question of genetic discrimination and wondered whether
knowledge of human genetic variation would increase or reduce prejudice. Her talk illustrated
the ground reality in genetic testing where knowledge need not always be comforting and
the dilemmas posed before persons who opt for genetic testing. Such an analysis of the
range of issues from lack of insurance to lack of adequate number of trained doctors/
counselors drove home the point that genetic testing and the outcomes could not be viewed
in isolation of social contexts, values and preferences.
Dr. Linda MacDonald Glenn (Albany Medical Center, New York) made a presentation on
‘Human Genome Research + Converging Technologies = The Singularity?’. She argued
that law had classified persons and objects either as person or as property but that was
changing and there was a continuum and animals were considered as property and not
as full persons. She pointed out that the idea of quasi-property and associated property
rights had to be constructed in case of embryos as their ownership and commodification
created problems for traditional concepts of property or person. She highlighted the
technological convergence that involved genetics, nanotechnology, and robotics and the
concerns related to the convergence for privacy, access and the societal impacts of
such convergence. Turning her attention to the ethics of patenting of genes and gene
sequences she spoke about the controversy over patenting BRCA1 and BRCA2 genes
and the judgment that declared such patents as invalid. She also mentioned and welcomed
the position taken by the United States Department of Justice in this, which supported the
idea that genes as occurring in nature should not be patented. Her talk focused on the
legal aspects of ELSI in genomics research and issues in extending Intellecutal Property
rights over genetic knowledge. A participant raised the question of the relationship between
law and ethics and pointed out that the law often laid the parameters of what constituted
ethics.
In his talk Prof. Venkat Rao (English and Foreign Languages University, Hyderabad) gave
a scathing critique of European modernity and the violence that was unleashed by it over
humanity. He was skeptical about the grand claims of progress, science and modernity
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and stressed the need to think in terms of new conceptual frameworks that were informed
by post-modernist thinking and are sensitive to the realities of post-colonial societies. He
drew attention to metaphors like ‘Book of Life’ and pointed out that the new possibilities
opened up by Information and Communication Technologies that enable archivisation
and embodiment outside the body and the resulting new ways of inscriptions that facilitated
encoding flesh as data and vice versa. In his talk he drew upon ideas like ‘biocapital’,
‘surplus health’ and recent theories by Nicholas Rose and pointed out that technological
possibilities could mean striving for sovereignty over everything and more desire for control.
Thus, according to him, what was at stake was life itself, in somatic, body/molecular
levels. To counter this he suggested we would need to draw upon different heritages of
Europe and recent works in STS, biopolitics, and anthropology of techno-science so that
non-European cultures could handle these developments and provide different forms of
cultural understanding and response than to buy the universal claims of technoscience
and its totalizing visions that enable new technologies of control. His presentation
highlighted how critical humanities could be useful for us in both understanding and
responding to these developments in life sciences.
Drawing upon his expertise in philosophy of biology Dr. M.G. Narasimhan (NIAS,
Bangalore), in his presentation, drew upon debates on the idea of the gene and the use
and abuses of genetic information and argued that in the name of ethics options in
research and search for knowledge should not be pre-empted. He began with a
description of DNA and the Central Dogma of Molecular Biology which described the
coming together of the theory of evolution and the new Genetics. He pointed out that
with the growing anxiety about genetic determinism. He explored the idea of genetic
information as a biological entity and the implications of this idea and the definitions
associated with this idea. He explained that the three main uses of genetic information
(i) as a tool of identification at the level of the individual, (ii) as a diagnostic tool and (iii)
in the context of predictive screening. He illustrated the abuses of genetic information
in different contexts ranging from eugenics to discrimination by insurance firms.
Describing the shortcomings of a genes-centered approach in biomedicine he drew
attention to the alternative approach suggested by Kegley and favoured a dialogic
approach in decision making in the context of genetic analysis and its implications. He
pointed out the dilemmas in possessing genetic information and handling it, and put
forth the case for a global watch body over abuse of genetic information on a massive
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scale. His talk brought together concepts in biomedicine, theoretical debates, and the
use and abuse of genetic information and cautioned against genetic determinism even
as he pointed out that ethics should play a role in these but that should not be based on
apriori assumptions about beneficial and malevolent aspects of research.
Dr. Norma Tsotsi (Steve Biko Centre for Bio-ethics, University of Witswatersrand,South
Africa) started with a description of the death of Steve Biko, a leader in the anti-apartheid
movement in South Africa and explained how doctors were complicit in that and also
pointed out that ultimately it was some other doctors who brought out the truth. She then
spoke about the activities of the centre and described how South African society was still
struggling with the after effects of the Apartheid regime. She described the ethnic diversity
in South Africa and the significance of this diversity in a country where 80 percent of the
population was Black/African. She spoke about the gaps in regulating biomedicine in
South Africa and pointed that out that the law was silent on the use of genetic information.
Peter deSouza pointed out that Dr. Tsotsi presented a developing country perspective
and the importance of  understanding the use and abuse of research on human genome
in diverse contexts and conditions.
The next presentation by Dr.K.Thangaraj (Centre for Molecular Biology, Hyderabad) was
keenly watched by participants as he presented the findings of a series of studies based
on the analysis of genetic samples collected from various groups in India including that of
indigenous groups in Andaman. He drew attention to the fact that certain groups were
more vulnerable to some diseases due to their genetic make up and this had implications
for prevention and diagnosis. He then presented the findings that showed the ‘genetic
distance’ among groups and the uniformity and diversity in groups in India and explained
the classifications used in the studies. He pointed out that due to endogamous marriage
and closely knit kinship patterns in India the gene pools within groups showed remarkable
uniformity although due to various factors there had been intermingling of genes from
different groups at different times and in different regions. According to him different Indian
groups had inherited different proportions of ancestry and he concluded by highlighting
the possible factors that resulted in high genetic drift in India.
Questions were raised about the classification and assumptions behind these studies
and how the scientists used concepts like caste, ethnic groups in these studies.
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Dr.Thangaraj underscored the fact that the expertise of anthropologists was used and
the work by Anthropological Survey of India (People of India project) was also used. Many
questions were raised on the implications of these findings for social sciences and their
understanding of Indian society but given the wide range of questions and the need to
understand the findings of these studies a separate workshop/conference involving more
scientists and social scientists would be desirable as due to lack of time and other factors
discussions on these issues in this conference had to be limited. Nevertheless the
presentation could be seen as a curtain raiser and the response it drew pointed to the
need for more social scientists to engage in such research and for further understanding
of the findings. The need for the ‘two cultures’ to talk to each other rather than talk past
each other was highlighted in this session .
The last two presentations by Prof. Peter Glasner (Sociologist, University of Cardiff, United
Kingdom) and Prof. Shiv Visvanathan (DAIIT, Ahmedabad) were interesting and provocative.
Peter Glasner needed no introduction as he had been addressing issues on genetics and
society for more than two decades. Glasner’s presentation titled as ‘Topologies of
Genome: Mapping the New Genomic Era’ covered a whole gamut of issues from the
visions of gene to the emerging bioeconomies in India. Starting with the genealogy of
HGP and the gene as a cultural icon he pointed out the differences in the representations
of the gene as articulated by different stakeholders. Describing the maps, topologies and
metaphors of the genome he pointed out that proprietary products had been created by
different types of samples, making genes as a mobile commodity. He suggested that the
terms bio-economy, bio-materials, bio-value and bio-knowledge could be the new
currencies. He described the topologies of global flows ranging from trust to personnel,
from materials to standards and the multiple topologies and expectations of different
stakeholders. He elaborated the promises of genomics and how the anticipated promises
were guiding research and development, providing legitimacy and attracting funding. He
presented some hard facts that challenged the myth that genetic medicine was about to
fulfill its promise. He discussed the emergence of bioeconomies and using, stem cells
as a case study he mapped the various sites and nodes in the bioeconomy of stem cells
that transcended national boundaries and showed that a developing country such as
India was inscribed into this and there was a value chain in India that covered different
aspects from materials to treatment and research. Drawing upon the book ‘Local Cells,
Global Science: The Rise of Embryonic Stem Cell Research in India’ he argued that
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legally non-binding regulations provided flexible spaces and facilitated rapid development
in India in this field. Thus he argued that the global and local are fluid, with occasionally
converging and conventional polarities being blurred. Calling for social scientists to deal
with the topologies of the genome without succumbing to the hyperboles, Prof. Glasner’s
presentation showed how social scientists could map the flows across space in genetic
materials and rethink their understanding of national and global regimes in biotechnology
in the light of bioeconomies that were both  local and global, with clients and stakeholders
dispersed in different regions of the globe.
In his provocative presentation, Prof Shiv Visvanathan (DAIIT, Ahmedabad) spoke about
the need to create a framework for genomic discourse and suggested  that while the
formal constitution dealt with law, policy, economics etc., a tacit constitution to discuss
the categories and emergent challenges is needed. He argued that although Foucault’s
idea of biopower was useful it had little to say on bio-power as a notion of informatics. He
drew attention to the work of Paul Rabinow and the SynBERC project. He then contrasted
Mode I and Mode II and put forth the view that Mode III moves from uncertainty to
emergence2. According to him on Mode II and Mode III Indian experience in terms of science
studies and social movements could be relevant. Then he looked at the issue of diversity
and race in the context of the Human Genome Project and UNESCO’s earlier work on
race as a category and elucidated the views of RAFI (now ETC Group), Troy  Duster and
Cavalli-Sforza to argue that reflexive organizations that can cut across the opposition
between experts and lay persons are needed. He cited the work of Michael Callon on
French Muscular Dystrophy Patients’ Groups to suggest that a similar one in India could
work on the issue of sickle cell anemia among tribals in Gujarat. In the rest of the
presentation he called for a new commons of biology and made a plea for re-writing
philosophy and an invitation to an ethical world which one can consider as an ‘open work’.
2 Mode I and Mode II refers to forms of knowledge production as hypothesized by Gibbon, M. et. al. first in 1994 and
revisited in 2001. Mode I refers to typical academic, discipline bound knowledge whereas Mode II refers to problem
focused and interdisciplinary knowledge and production of this is not confined to academic institutions. It should be
noted that this hypothesis has been criticized and challenged. Mode III is put forth by  Shiv Visvanathan as a new/
another mode of producing knowledge. But Mode III science is a hypothesis put forth by Friedrich Hinterberger.
Since Shiv Visvanathan did not refer to this it is not clear as to whether he is referring to the hypothesis of Friedrich
Hinterberger or whether he is putting forth his hypothesis as Mode III. In the literature Mode I often means Mode I
science, Mode II means Mode II science and sometimes post-normal science and Mode II science are used as
synonyms. Gibbons, Michael; Camille Limoges, Helga Nowotny, Simon Schwartzman, Peter Scott, & Martin Trow
(1994). The new production of knowledge: the dynamics of science and research in contemporary societies.
London: Sage. Nowotny, Helga; Peter Scott & Michael Gibbons (2001). Rethinking science: knowledge in an age of
uncertainty. Cambridge: Polity.
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One of the participants asked whether he had abandoned the critique that he and Nandy
put forth in the late 1980s and whether this presentation was an acknowledgment of
taking a new position. Shiv Visvanathan clarified that while that critique was relevant then,
in today’s context one had to think beyond that and engage with science rather than
withdraw or refuse to participate.
At the final session some suggestions for follow up were made. These included building
up collaborative groups among scholars in India and other parts of the world. Another
suggestion was to hold more such conferences and explore new issues bringing together
scientists and social scientists. Both Beijker and Glasner were supportive of the first
suggestion. Prof. Peter deSouza suggested that an edited volume could be published in
2011 based on the papers/presentations made at the Conference. The conference
concluded with most members consenting to the need for India to develop better regulatory
frameworks to regulate research and application of genome research and for an all-India
body to consider the work of international groups, such as those in The Netherlands, to
enhance the democratization of human genome research and to bring in both transparency
and accountability in scientific and medical endeavours. All the participants also concurred
on the need for more intense conversations among disciplines so as to engage with the
social, ethical, and legal implications of the future human genomics research.
Part II: A summative overview and recommendations
for further activities
The conference should be seen as a beginning of a new initiative in interdisciplinary
research and advocacy. One of the outcomes of the conference, an edited volume should
be published between 2011-2012. The four sets of issues as enunciated by Prof. Peter
deSouza can be used a framework for further research and dialogue. The four sets are
overlapping and hence the interfaces have to be identified and on that basis groups can
be constituted to work on themes and specific issues. The Conference also revealed that
the conversation among scientists and social scientist can be mutually beneficial. In the
future more scientists should be invited and social scientists should be made aware of
the directions of genomics research in India, the funding patterns, research themes, their
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social relevance and impacts. A key suggestion from one of the senior participants, Prof
Sharat Chandra, was for the need for social science engagements and comments to be
accessible to the science establishment and the larger community. Given the currency
and spread of genetic testing and allied applied medical applications, there is a need for
a mapping of the current and proposed research in India in genomics and the related
ELSI aspects to be identified as a priority. For instance stem cell research in India is
being pursued at different institutions but the ELSI aspects have not been studied in
detail.
1. Further Studies and Research:
What is needed is a series of studies on various aspects including ethical, regulatory,
legal issues and the adequacy of the current regulatory regime to cope up with the
developments in science and technology. Prof. Madhava Menon pointed to the  possibility
of the human rights framework being the guiding principle in ensuring that genomics
research and application of technology does not violate the rights of the people of this
country. But, given that genome research has the possibility of being commercialized
and hence commodified, it can blur the borders between what is human, and
non-human, and lead to the creation of chimeras that can challenge our cherished
assumptions about humans, animals and nature. This aspect has been studied by
sociologist, anthropologists and we can draw upon this research to understand
developments in India.
2. Review of and implementation of regulatory regimes:
Another challenge is that in a globalized world, while the practice of science and technology
are getting universalized, the regulatory regimes are not. As a result what is unethical in
one country can be considered as perfectly acceptable in another country. With
governments taking the lead in promoting biosciences and encouraging commercialization
of technology, the regulatory regime in one country may not be sufficient to regulate genomic
research elsewhere. Researchers can migrate and samples can be procured and
therapies and treatments can be offered elsewhere although direct exports may not be
possible. Some studies indicate that there is a global market for stem cell therapy, tissues/
samples and ART (Assisted Reproductive Technologies) has resulted in more
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commodification of human reproduction. Given such trends, the legal framework in India
may be inadequate to address these issues and provide a just and ethical regulatory
mechanism.
3. Frameworks and Guidelines for ELSI in India
The challenge before us is to do research that is relevant in the Indian context while
drawing upon the works done elsewhere and we should identify issues that are specific
in Indian context and give importance to them. For example, by now there is enough
literature on genetic screening and testing in Europe and USA and the response of the
societies and communities to that. This has been supplemented with studies on regulation
of these screening practices and their place in overall health policy and regulation. But in
India, as Dr. Ratna Puri’s presentation pointed out, there is a need to understand the
genetic disease burden in India and develop capacity to ensure that genetic testing is
available to those who need it most. Of course the ethical issues remain and cannot be
wished away. But how families, couples and individuals respond to the testing and what
values and norms guide them and how they face this knowledge and cope with is important.
Informed policy making can be made on understanding these needs and orientations.
While we can draw upon studies developed elsewhere (e.g. Rayna Rapp’s work on
amniocentesis and Latino communities in USA, extensive studies across Europe on
response of various communities to genetic testing), there is need to pay attention to the
specificities of India’s social and family structures and cultural priorities.
It is here that there are exciting opportunities for sociologists of health and society,
medical anthropologists, psychologists to work with doctors and counselors to understand
how families in India respond to the screening and what role the changes in family
structures, kinship norms and modernization can play in the response to the tests. For
example, it will be worthwhile to understand how the nuclear family structure and desire
for single child / two children may influence couples’ preference for children with no genetic
disorders. Are couples who resort to ART also keen to undergo genetic testing? On the
other hand, we need studies on the issues faced by families that need support in terms of
insurance, access to care for children born with different genetic disabilities, and how
best their needs over a life span can be met. Another issue is whether genetic testing
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should be made mandatory in some cases or in some circumstances and whether
communities can be provided with screening options when the genetic disorder burden
is high and widespread. Obviously there are ethical issues that cannot be ignored but we
cannot wish away the reality and cite relative ethics as an excuse for inaction. In such
circumstances scientists, doctors and social scientists will be able to draw upon their
collective wisdom and conversations to help policy makers.
The ELSI aspects of genomics are overlapping, and this is inevitable. In terms of further
work, and building upon this conference, it is essential to identify themes/issues for more
focused work. Workshops can be organized on this basis (e.g. a workshop on genetic
testing in India and ELSI issues, a workshop on human genetics research in various
groups and the social scientists’ understanding of Indian society and insights from
population sampling, a workshop on the state of genomics research in India and related
ELSI issues). These workshops can be two-day events and the participation can be
limited to 25 to 30 persons. Some themes can be identified on a priority basis where work
has been done on this and where there is a wealth of literature and data to draw upon
while some themes can be identified for further work. Thus a series of workshops planned
over the next two years will enable us to move forward with a clear focus and deliver
outputs that help both policy makers, the academic community, and the larger community.
For instance a workshop on regulation of research, therapy and commercialization of
genomics can cover ELSI issues in clinical trials, stem cell research, biobanking etc and
identify the gaps in current frameworks, take into account prospective issues that would
need attention in future and can come up with suggestions for government. These
structured workshops will need studies as core inputs and the workshop itself will be a
forum to deliberate on the studies rather than to present them. For this a core group of
4 or 5 persons can be formed and the group in turn will identify the issues for preparing
the studies and commission them. The study reports can, in turn, be used both as back
ground papers and for deliberations as the reports will have both parts; analysis/survey of
issues, research questions, and proposed solutions/suggestions based on the analysis.
Each study in turn will be supplemented by brief papers/scoping notes and case studies.
Such an approach will draw upon experts in different fields and enable them to work
together in studying an issue with insights from their respective disciplines.
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4. Collaborative Studies and Research Networks:
In the USA, ELSI research in Human Genome Project was first funded by the Department
of Energy and NSF. There was active interest in these issues from civil society groups
and academics. The President’s Council on Bioethics published reports on various issues.
The most interesting aspect was that in many projects ELSI research provided ample
scope for inter-disciplinary and collaborative research and this was reflected in the
outcomes ranging from edited volumes to articles/papers. In the UK, ESRC played an
important role in this research by funding centers/units in different Universities. These
centers are still active and have produced a significant body of scholarship. Many countries
in Europe provided funding for ELSI through various ministries, councils and centers in
universities. Institutions working on Science, Technology and Society (STS) issues took
active interest and as a result there was a cross-fertilization of ideas. Nordic countries
were no exception to this and some of the interesting work in Europe has come out of
countries like Norway and Denmark. In India funding for such research can be provided
by different agencies such as ICMR, DBT, UGC, and DST. A suggestion in this regard is
that to begin with, the DST, DBT, UGC, ICSSR and Ministry of HRD can form a consortium
with other agencies/departments to call for, evaluate and fund such studies. The ESRC’s
model of funding centers can also be considered. It is important to involve institutions like
CSIR, Anthropological Survey of India in these initiatives. DBT and ICMR can be requested
to set aside 2-3% of the funds allocated for genomics research to fund ELSI centers and
support them for five years to begin with. These centers can focus on specific issues/
themes and can provide inputs to policy making besides helping DBT and ICMR in
formulating regulatory policies and in addressing ethical concerns in research and
commercialization.
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